Consecutive RAS dysregulation with relative upregulation of the ACE/angiotensin (Ang) I/Ang II axis and downregulation of the alternative ACE2/Ang (1–7) system is crucial in patients with COVID-19 [9,10]. The gene discussed is AGT; the disease is COVID-19.